Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Standard Hypercaloric, Hyperproteic vs Leucine-enriched Oral Supplements in Patients With Cancer-induced Sarcopenia

Authors not listed

Maimónides Biomedical Research Institute of Córdoba · 2021

Abstract

Currently there is a lack of evidence for recommending specific oral supplements (OS) for nutritional support in patients with cancer, including leucine-enriched supplements.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Anonymous. (2021). Standard Hypercaloric, Hyperproteic vs Leucine-enriched Oral Supplements in Patients With Cancer-induced Sarcopenia. <em>Maimónides Biomedical Research Institute of Córdoba</em>. https://clinicaltrials.gov/study/NCT05837741
Vancouver
Anonymous. Standard Hypercaloric, Hyperproteic vs Leucine-enriched Oral Supplements in Patients With Cancer-induced Sarcopenia. Maimónides Biomedical Research Institute of Córdoba. 2021.
BibTeX
@misc{anon2021Standa, title = {Standard Hypercaloric, Hyperproteic vs Leucine-enriched Oral Supplements in Patients With Cancer-induced Sarcopenia}, author = {Anonymous}, journal = {Maimónides Biomedical Research Institute of Córdoba}, year = {2021}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings